nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—CYP2A6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0159	0.0527	CbGpPWpGaD
Selegiline—Peripheral vascular disorder—Varenicline—nicotine dependence	0.013	0.0187	CcSEcCtD
Selegiline—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0129	0.0425	CbGpPWpGaD
Selegiline—Throat irritation—Varenicline—nicotine dependence	0.0127	0.0182	CcSEcCtD
Selegiline—CYP2E1—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0126	0.0416	CbGpPWpGaD
Selegiline—Hostility—Varenicline—nicotine dependence	0.0115	0.0165	CcSEcCtD
Selegiline—Sexual dysfunction—Varenicline—nicotine dependence	0.0114	0.0163	CcSEcCtD
Selegiline—Sleep disturbance—Varenicline—nicotine dependence	0.0114	0.0163	CcSEcCtD
Selegiline—Osteoporosis—Varenicline—nicotine dependence	0.0114	0.0163	CcSEcCtD
Selegiline—Suicide attempt—Varenicline—nicotine dependence	0.0113	0.0161	CcSEcCtD
Selegiline—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0109	0.036	CbGpPWpGaD
Selegiline—Libido increased—Varenicline—nicotine dependence	0.0105	0.0151	CcSEcCtD
Selegiline—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.01	0.0332	CbGpPWpGaD
Selegiline—CYP2A6—Xenobiotics—CYP2A7—nicotine dependence	0.00988	0.0327	CbGpPWpGaD
Selegiline—Parosmia—Varenicline—nicotine dependence	0.00985	0.0141	CcSEcCtD
Selegiline—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00972	0.0321	CbGpPWpGaD
Selegiline—Intestinal obstruction—Varenicline—nicotine dependence	0.00937	0.0134	CcSEcCtD
Selegiline—Paranoia—Varenicline—nicotine dependence	0.00937	0.0134	CcSEcCtD
Selegiline—Delusion—Varenicline—nicotine dependence	0.00903	0.0129	CcSEcCtD
Selegiline—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00894	0.0295	CbGpPWpGaD
Selegiline—Hyperlipidaemia—Varenicline—nicotine dependence	0.00887	0.0127	CcSEcCtD
Selegiline—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00886	0.0293	CbGpPWpGaD
Selegiline—Mania—Varenicline—nicotine dependence	0.00879	0.0126	CcSEcCtD
Selegiline—Menorrhagia—Varenicline—nicotine dependence	0.00863	0.0124	CcSEcCtD
Selegiline—Scotoma—Varenicline—nicotine dependence	0.00841	0.0121	CcSEcCtD
Selegiline—Fungal infection—Varenicline—nicotine dependence	0.00828	0.0119	CcSEcCtD
Selegiline—Gingivitis—Varenicline—nicotine dependence	0.00814	0.0117	CcSEcCtD
Selegiline—Mydriasis—Varenicline—nicotine dependence	0.00801	0.0115	CcSEcCtD
Selegiline—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.00797	0.0263	CbGpPWpGaD
Selegiline—Nephrolithiasis—Varenicline—nicotine dependence	0.00795	0.0114	CcSEcCtD
Selegiline—CYP2E1—Xenobiotics—CYP2A7—nicotine dependence	0.00781	0.0258	CbGpPWpGaD
Selegiline—Aggression—Varenicline—nicotine dependence	0.00727	0.0104	CcSEcCtD
Selegiline—Accidental injury—Varenicline—nicotine dependence	0.00722	0.0104	CcSEcCtD
Selegiline—Viral infection—Varenicline—nicotine dependence	0.00707	0.0101	CcSEcCtD
Selegiline—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00707	0.0101	CcSEcCtD
Selegiline—Thinking abnormal—Varenicline—nicotine dependence	0.00698	0.01	CcSEcCtD
Selegiline—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00697	0.0231	CbGpPWpGaD
Selegiline—Nocturia—Varenicline—nicotine dependence	0.00689	0.00988	CcSEcCtD
Selegiline—MAOB—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00683	0.0226	CbGpPWpGaD
Selegiline—Leukocytosis—Varenicline—nicotine dependence	0.0068	0.00975	CcSEcCtD
Selegiline—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00675	0.0223	CbGpPWpGaD
Selegiline—Coordination abnormal—Varenicline—nicotine dependence	0.00651	0.00933	CcSEcCtD
Selegiline—Abnormal dreams—Varenicline—nicotine dependence	0.00631	0.00905	CcSEcCtD
Selegiline—Eructation—Varenicline—nicotine dependence	0.00628	0.009	CcSEcCtD
Selegiline—Hyperkalaemia—Varenicline—nicotine dependence	0.00628	0.009	CcSEcCtD
Selegiline—Salivary hypersecretion—Varenicline—nicotine dependence	0.00621	0.0089	CcSEcCtD
Selegiline—Nightmare—Varenicline—nicotine dependence	0.00617	0.00885	CcSEcCtD
Selegiline—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00602	0.0199	CbGpPWpGaD
Selegiline—Dry eye—Varenicline—nicotine dependence	0.0059	0.00846	CcSEcCtD
Selegiline—Oesophagitis—Varenicline—nicotine dependence	0.00584	0.00837	CcSEcCtD
Selegiline—Urine output increased—Varenicline—nicotine dependence	0.00578	0.00828	CcSEcCtD
Selegiline—Hypertonia—Varenicline—nicotine dependence	0.0056	0.00803	CcSEcCtD
Selegiline—Mental disability—Varenicline—nicotine dependence	0.00555	0.00795	CcSEcCtD
Selegiline—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00554	0.0183	CbGpPWpGaD
Selegiline—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00549	0.0182	CbGpPWpGaD
Selegiline—Euphoric mood—Varenicline—nicotine dependence	0.00549	0.00787	CcSEcCtD
Selegiline—Lymphadenopathy—Varenicline—nicotine dependence	0.00544	0.00779	CcSEcCtD
Selegiline—Sleep disorder—Varenicline—nicotine dependence	0.00536	0.00768	CcSEcCtD
Selegiline—Diabetes mellitus—Varenicline—nicotine dependence	0.00533	0.00765	CcSEcCtD
Selegiline—Polyuria—Varenicline—nicotine dependence	0.00528	0.00757	CcSEcCtD
Selegiline—Deafness—Varenicline—nicotine dependence	0.00519	0.00743	CcSEcCtD
Selegiline—Disorientation—Varenicline—nicotine dependence	0.00519	0.00743	CcSEcCtD
Selegiline—Eczema—Varenicline—nicotine dependence	0.00516	0.0074	CcSEcCtD
Selegiline—Eye pain—Varenicline—nicotine dependence	0.00514	0.00737	CcSEcCtD
Selegiline—Injury—Varenicline—nicotine dependence	0.00505	0.00723	CcSEcCtD
Selegiline—Libido decreased—Varenicline—nicotine dependence	0.005	0.00717	CcSEcCtD
Selegiline—Increased appetite—Varenicline—nicotine dependence	0.00494	0.00708	CcSEcCtD
Selegiline—Amnesia—Varenicline—nicotine dependence	0.00494	0.00708	CcSEcCtD
Selegiline—Atrial fibrillation—Varenicline—nicotine dependence	0.00489	0.00702	CcSEcCtD
Selegiline—Thirst—Varenicline—nicotine dependence	0.00487	0.00699	CcSEcCtD
Selegiline—Arthritis—Varenicline—nicotine dependence	0.00477	0.00684	CcSEcCtD
Selegiline—Hypoglycaemia—Varenicline—nicotine dependence	0.00475	0.00681	CcSEcCtD
Selegiline—Lethargy—Varenicline—nicotine dependence	0.00473	0.00679	CcSEcCtD
Selegiline—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00469	0.0155	CbGpPWpGaD
Selegiline—Osteoarthritis—Varenicline—nicotine dependence	0.00464	0.00665	CcSEcCtD
Selegiline—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00464	0.00665	CcSEcCtD
Selegiline—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.0046	0.0066	CcSEcCtD
Selegiline—Migraine—Varenicline—nicotine dependence	0.00457	0.00655	CcSEcCtD
Selegiline—Affect lability—Varenicline—nicotine dependence	0.00457	0.00655	CcSEcCtD
Selegiline—Psychotic disorder—Varenicline—nicotine dependence	0.00453	0.00649	CcSEcCtD
Selegiline—Irritability—Varenicline—nicotine dependence	0.00443	0.00635	CcSEcCtD
Selegiline—Urinary retention—Varenicline—nicotine dependence	0.00441	0.00632	CcSEcCtD
Selegiline—Mood swings—Varenicline—nicotine dependence	0.00439	0.0063	CcSEcCtD
Selegiline—MAOA—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00428	0.0142	CbGpPWpGaD
Selegiline—Liver function test abnormal—Varenicline—nicotine dependence	0.00428	0.00614	CcSEcCtD
Selegiline—Dry skin—Varenicline—nicotine dependence	0.00425	0.0061	CcSEcCtD
Selegiline—Hypokalaemia—Varenicline—nicotine dependence	0.00422	0.00605	CcSEcCtD
Selegiline—Cramp muscle—Varenicline—nicotine dependence	0.00418	0.00599	CcSEcCtD
Selegiline—Gastritis—Varenicline—nicotine dependence	0.00411	0.00589	CcSEcCtD
Selegiline—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0041	0.0136	CbGpPWpGaD
Selegiline—CYP2A6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00405	0.0134	CbGpPWpGaD
Selegiline—Asthma—Varenicline—nicotine dependence	0.00401	0.00575	CcSEcCtD
Selegiline—Dysphagia—Varenicline—nicotine dependence	0.00401	0.00575	CcSEcCtD
Selegiline—Angina pectoris—Varenicline—nicotine dependence	0.00391	0.0056	CcSEcCtD
Selegiline—Bronchitis—Varenicline—nicotine dependence	0.00386	0.00553	CcSEcCtD
Selegiline—Pollakiuria—Varenicline—nicotine dependence	0.0037	0.00531	CcSEcCtD
Selegiline—Erectile dysfunction—Varenicline—nicotine dependence	0.00369	0.00529	CcSEcCtD
Selegiline—Photosensitivity reaction—Varenicline—nicotine dependence	0.00366	0.00525	CcSEcCtD
Selegiline—Weight increased—Varenicline—nicotine dependence	0.00365	0.00523	CcSEcCtD
Selegiline—MAOB—Biological oxidations—CYP2A7—nicotine dependence	0.00363	0.012	CbGpPWpGaD
Selegiline—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00362	0.012	CbGpPWpGaD
Selegiline—Hyperglycaemia—Varenicline—nicotine dependence	0.00362	0.00518	CcSEcCtD
Selegiline—Depression—Varenicline—nicotine dependence	0.00356	0.00511	CcSEcCtD
Selegiline—Acute coronary syndrome—Varenicline—nicotine dependence	0.00352	0.00505	CcSEcCtD
Selegiline—Myocardial infarction—Varenicline—nicotine dependence	0.0035	0.00502	CcSEcCtD
Selegiline—Stomatitis—Varenicline—nicotine dependence	0.00348	0.005	CcSEcCtD
Selegiline—Conjunctivitis—Varenicline—nicotine dependence	0.00347	0.00498	CcSEcCtD
Selegiline—Hepatobiliary disease—Varenicline—nicotine dependence	0.00338	0.00485	CcSEcCtD
Selegiline—Epistaxis—Varenicline—nicotine dependence	0.00337	0.00483	CcSEcCtD
Selegiline—Sinusitis—Varenicline—nicotine dependence	0.00335	0.00481	CcSEcCtD
Selegiline—CYP2A6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00333	0.011	CbGpPWpGaD
Selegiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00331	0.0109	CbGpPWpGaD
Selegiline—Bradycardia—Varenicline—nicotine dependence	0.00327	0.00468	CcSEcCtD
Selegiline—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00327	0.0108	CbGpPWpGaD
Selegiline—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00324	0.0107	CbGpPWpGaD
Selegiline—CYP2E1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0032	0.0106	CbGpPWpGaD
Selegiline—Hypoaesthesia—Varenicline—nicotine dependence	0.00319	0.00458	CcSEcCtD
Selegiline—Hallucination—Varenicline—nicotine dependence	0.00319	0.00458	CcSEcCtD
Selegiline—Urinary tract disorder—Varenicline—nicotine dependence	0.00317	0.00454	CcSEcCtD
Selegiline—Oedema peripheral—Varenicline—nicotine dependence	0.00316	0.00453	CcSEcCtD
Selegiline—Urethral disorder—Varenicline—nicotine dependence	0.00315	0.00451	CcSEcCtD
Selegiline—Visual impairment—Varenicline—nicotine dependence	0.00309	0.00443	CcSEcCtD
Selegiline—Tinnitus—Varenicline—nicotine dependence	0.00299	0.00429	CcSEcCtD
Selegiline—MAOA—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00294	0.00973	CbGpPWpGaD
Selegiline—Angiopathy—Varenicline—nicotine dependence	0.00291	0.00417	CcSEcCtD
Selegiline—Chills—Varenicline—nicotine dependence	0.00288	0.00413	CcSEcCtD
Selegiline—Arrhythmia—Varenicline—nicotine dependence	0.00287	0.00411	CcSEcCtD
Selegiline—Mental disorder—Varenicline—nicotine dependence	0.00281	0.00403	CcSEcCtD
Selegiline—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0028	0.00926	CbGpPWpGaD
Selegiline—Malnutrition—Varenicline—nicotine dependence	0.00279	0.004	CcSEcCtD
Selegiline—Erythema—Varenicline—nicotine dependence	0.00279	0.004	CcSEcCtD
Selegiline—MAOA—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00279	0.00922	CbGpPWpGaD
Selegiline—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00277	0.00914	CbGpPWpGaD
Selegiline—Flatulence—Varenicline—nicotine dependence	0.00275	0.00395	CcSEcCtD
Selegiline—Dysgeusia—Varenicline—nicotine dependence	0.00274	0.00392	CcSEcCtD
Selegiline—Back pain—Varenicline—nicotine dependence	0.0027	0.00387	CcSEcCtD
Selegiline—Muscle spasms—Varenicline—nicotine dependence	0.00269	0.00385	CcSEcCtD
Selegiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00268	0.00887	CbGpPWpGaD
Selegiline—Vision blurred—Varenicline—nicotine dependence	0.00263	0.00377	CcSEcCtD
Selegiline—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00263	0.00869	CbGpPWpGaD
Selegiline—Tremor—Varenicline—nicotine dependence	0.00262	0.00375	CcSEcCtD
Selegiline—Ill-defined disorder—Varenicline—nicotine dependence	0.00259	0.00372	CcSEcCtD
Selegiline—Anaemia—Varenicline—nicotine dependence	0.00258	0.0037	CcSEcCtD
Selegiline—Agitation—Varenicline—nicotine dependence	0.00257	0.00368	CcSEcCtD
Selegiline—Malaise—Varenicline—nicotine dependence	0.00252	0.00361	CcSEcCtD
Selegiline—Vertigo—Varenicline—nicotine dependence	0.00251	0.0036	CcSEcCtD
Selegiline—Syncope—Varenicline—nicotine dependence	0.00251	0.00359	CcSEcCtD
Selegiline—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0025	0.00827	CbGpPWpGaD
Selegiline—Palpitations—Varenicline—nicotine dependence	0.00247	0.00354	CcSEcCtD
Selegiline—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00247	0.00816	CbGpPWpGaD
Selegiline—Loss of consciousness—Varenicline—nicotine dependence	0.00246	0.00352	CcSEcCtD
Selegiline—Cough—Varenicline—nicotine dependence	0.00244	0.00349	CcSEcCtD
Selegiline—Convulsion—Varenicline—nicotine dependence	0.00242	0.00347	CcSEcCtD
Selegiline—Hypertension—Varenicline—nicotine dependence	0.00241	0.00346	CcSEcCtD
Selegiline—Arthralgia—Varenicline—nicotine dependence	0.00238	0.00341	CcSEcCtD
Selegiline—Myalgia—Varenicline—nicotine dependence	0.00238	0.00341	CcSEcCtD
Selegiline—Chest pain—Varenicline—nicotine dependence	0.00238	0.00341	CcSEcCtD
Selegiline—Anxiety—Varenicline—nicotine dependence	0.00237	0.0034	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00236	0.00339	CcSEcCtD
Selegiline—MAOA—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00236	0.0078	CbGpPWpGaD
Selegiline—Discomfort—Varenicline—nicotine dependence	0.00235	0.00337	CcSEcCtD
Selegiline—Dry mouth—Varenicline—nicotine dependence	0.00233	0.00333	CcSEcCtD
Selegiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0023	0.0076	CbGpPWpGaD
Selegiline—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00228	0.00754	CbGpPWpGaD
Selegiline—Oedema—Varenicline—nicotine dependence	0.00228	0.00327	CcSEcCtD
Selegiline—MAOA—Biological oxidations—CYP2A7—nicotine dependence	0.00228	0.00752	CbGpPWpGaD
Selegiline—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00227	0.00751	CbGpPWpGaD
Selegiline—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00227	0.0075	CbGpPWpGaD
Selegiline—Infection—Varenicline—nicotine dependence	0.00226	0.00325	CcSEcCtD
Selegiline—MAOA—Neuronal System—CHRNB3—nicotine dependence	0.00225	0.00745	CbGpPWpGaD
Selegiline—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00225	0.00744	CbGpPWpGaD
Selegiline—Shock—Varenicline—nicotine dependence	0.00224	0.00322	CcSEcCtD
Selegiline—Nervous system disorder—Varenicline—nicotine dependence	0.00224	0.00321	CcSEcCtD
Selegiline—Thrombocytopenia—Varenicline—nicotine dependence	0.00223	0.0032	CcSEcCtD
Selegiline—Tachycardia—Varenicline—nicotine dependence	0.00223	0.00319	CcSEcCtD
Selegiline—Skin disorder—Varenicline—nicotine dependence	0.00221	0.00317	CcSEcCtD
Selegiline—Hyperhidrosis—Varenicline—nicotine dependence	0.0022	0.00316	CcSEcCtD
Selegiline—Anorexia—Varenicline—nicotine dependence	0.00217	0.00312	CcSEcCtD
Selegiline—MAOA—Neuronal System—CHRNA6—nicotine dependence	0.00214	0.00707	CbGpPWpGaD
Selegiline—Hypotension—Varenicline—nicotine dependence	0.00213	0.00305	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00208	0.00298	CcSEcCtD
Selegiline—Insomnia—Varenicline—nicotine dependence	0.00206	0.00296	CcSEcCtD
Selegiline—Dyspnoea—Varenicline—nicotine dependence	0.00203	0.00291	CcSEcCtD
Selegiline—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00203	0.0067	CbGpPWpGaD
Selegiline—Somnolence—Varenicline—nicotine dependence	0.00203	0.00291	CcSEcCtD
Selegiline—MAOA—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00202	0.00667	CbGpPWpGaD
Selegiline—Dyspepsia—Varenicline—nicotine dependence	0.00201	0.00288	CcSEcCtD
Selegiline—Decreased appetite—Varenicline—nicotine dependence	0.00198	0.00284	CcSEcCtD
Selegiline—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00197	0.00282	CcSEcCtD
Selegiline—Fatigue—Varenicline—nicotine dependence	0.00197	0.00282	CcSEcCtD
Selegiline—Constipation—Varenicline—nicotine dependence	0.00195	0.00279	CcSEcCtD
Selegiline—Pain—Varenicline—nicotine dependence	0.00195	0.00279	CcSEcCtD
Selegiline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00195	0.00644	CbGpPWpGaD
Selegiline—MAOA—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00193	0.00639	CbGpPWpGaD
Selegiline—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00192	0.00636	CbGpPWpGaD
Selegiline—Feeling abnormal—Varenicline—nicotine dependence	0.00188	0.00269	CcSEcCtD
Selegiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00186	0.00617	CbGpPWpGaD
Selegiline—Gastrointestinal pain—Varenicline—nicotine dependence	0.00186	0.00267	CcSEcCtD
Selegiline—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00185	0.00611	CbGpPWpGaD
Selegiline—Urticaria—Varenicline—nicotine dependence	0.00181	0.0026	CcSEcCtD
Selegiline—Abdominal pain—Varenicline—nicotine dependence	0.0018	0.00258	CcSEcCtD
Selegiline—Body temperature increased—Varenicline—nicotine dependence	0.0018	0.00258	CcSEcCtD
Selegiline—MAOA—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.0018	0.00594	CbGpPWpGaD
Selegiline—CYP2A6—Biological oxidations—CYP2A7—nicotine dependence	0.00177	0.00584	CbGpPWpGaD
Selegiline—Hypersensitivity—Varenicline—nicotine dependence	0.00168	0.00241	CcSEcCtD
Selegiline—Asthenia—Varenicline—nicotine dependence	0.00164	0.00234	CcSEcCtD
Selegiline—Pruritus—Varenicline—nicotine dependence	0.00161	0.00231	CcSEcCtD
Selegiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00158	0.00522	CbGpPWpGaD
Selegiline—MAOA—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00157	0.0052	CbGpPWpGaD
Selegiline—Diarrhoea—Varenicline—nicotine dependence	0.00156	0.00224	CcSEcCtD
Selegiline—MAOA—Neuronal System—GABRA4—nicotine dependence	0.00155	0.00511	CbGpPWpGaD
Selegiline—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00151	0.005	CbGpPWpGaD
Selegiline—Dizziness—Varenicline—nicotine dependence	0.00151	0.00216	CcSEcCtD
Selegiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0015	0.00497	CbGpPWpGaD
Selegiline—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00148	0.00491	CbGpPWpGaD
Selegiline—MAOA—Neuronal System—CHRNB4—nicotine dependence	0.00148	0.0049	CbGpPWpGaD
Selegiline—CYP2E1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00148	0.0049	CbGpPWpGaD
Selegiline—MAOA—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00147	0.00484	CbGpPWpGaD
Selegiline—Vomiting—Varenicline—nicotine dependence	0.00145	0.00208	CcSEcCtD
Selegiline—Rash—Varenicline—nicotine dependence	0.00144	0.00206	CcSEcCtD
Selegiline—Dermatitis—Varenicline—nicotine dependence	0.00144	0.00206	CcSEcCtD
Selegiline—MAOA—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00143	0.00472	CbGpPWpGaD
Selegiline—Headache—Varenicline—nicotine dependence	0.00143	0.00205	CcSEcCtD
Selegiline—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.00143	0.00471	CbGpPWpGaD
Selegiline—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00141	0.00465	CbGpPWpGaD
Selegiline—CYP2E1—Biological oxidations—CYP2A7—nicotine dependence	0.0014	0.00461	CbGpPWpGaD
Selegiline—MAOA—Neuronal System—CHRNA5—nicotine dependence	0.00138	0.00455	CbGpPWpGaD
Selegiline—CYP2E1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00138	0.00455	CbGpPWpGaD
Selegiline—Nausea—Varenicline—nicotine dependence	0.00135	0.00194	CcSEcCtD
Selegiline—MAOA—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00129	0.00426	CbGpPWpGaD
Selegiline—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00128	0.00423	CbGpPWpGaD
Selegiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00122	0.00403	CbGpPWpGaD
Selegiline—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.00121	0.00399	CbGpPWpGaD
Selegiline—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00119	0.00393	CbGpPWpGaD
Selegiline—MAOA—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00117	0.00387	CbGpPWpGaD
Selegiline—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00114	0.00378	CbGpPWpGaD
Selegiline—MAOA—Neuronal System—CHRNA3—nicotine dependence	0.00112	0.00371	CbGpPWpGaD
Selegiline—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.00108	0.00356	CbGpPWpGaD
Selegiline—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00106	0.00351	CbGpPWpGaD
Selegiline—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00105	0.00347	CbGpPWpGaD
Selegiline—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00104	0.00344	CbGpPWpGaD
Selegiline—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000991	0.00327	CbGpPWpGaD
Selegiline—MAOA—Neuronal System—CHRNB2—nicotine dependence	0.000988	0.00327	CbGpPWpGaD
Selegiline—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000982	0.00325	CbGpPWpGaD
Selegiline—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000977	0.00323	CbGpPWpGaD
Selegiline—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000968	0.0032	CbGpPWpGaD
Selegiline—MAOA—Neuronal System—CHRNA4—nicotine dependence	0.000898	0.00297	CbGpPWpGaD
Selegiline—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00089	0.00294	CbGpPWpGaD
Selegiline—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000839	0.00277	CbGpPWpGaD
Selegiline—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000828	0.00274	CbGpPWpGaD
Selegiline—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000687	0.00227	CbGpPWpGaD
Selegiline—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000648	0.00214	CbGpPWpGaD
Selegiline—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000639	0.00211	CbGpPWpGaD
Selegiline—MAOB—Metabolism—CYP2A7—nicotine dependence	0.00062	0.00205	CbGpPWpGaD
Selegiline—MAOA—Metabolism—CYP2A7—nicotine dependence	0.000389	0.00129	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000384	0.00127	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CYP2A7—nicotine dependence	0.000302	0.000999	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.000244	0.000806	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CYP2A7—nicotine dependence	0.000239	0.000789	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000206	0.000682	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000184	0.000609	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.00018	0.000594	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000169	0.00056	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000168	0.000555	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000144	0.000474	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000111	0.000366	CbGpPWpGaD
